Asia Pacific Periodontal Disease Treatment Market

The report "Asia Pacific Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Country - Forecast to 2031" is projected to grow from USD 0.91 billion by 2031  and to reach USD 0.64 billion in 2026, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.

Browse 250 market data Tables and 60 Figures spread through 270 Pages and in-depth TOC on "Asia Pacific Periodontal Disease Treatment Market by Product (Equipment, Consumables), Disease (Gingivitis, Periodontitis), Treatment (Bone Grafting, Scaling, Flap Surgery, Regeneration), End User (Clinics, Private DSOs), and Country - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/apac-periodontal-disease-treatment-market-34276109.html

The Asia Pacific periodontal disease treatment market is driven significantly by the growing prevalence of oral health disorders, including periodontal disease, gingivitis, and other chronic dental conditions, which continue to affect a substantial portion of the population. Rising cases of edentulism, especially among elderly individuals and patients with long-standing periodontal issues, are increasing the demand for advanced periodontal therapies and supporting equipment. Moreover, the emergence of innovative dental treatment procedures, such as laser-based therapies, minimally invasive surgical techniques, and digitally enabled periodontal solutions, is enhancing treatment effectiveness, reducing recovery time, and encouraging adoption among dental professionals. In addition, the expanding dental tourism market in emerging economies is intensifying global competition, motivating Asia Pacific manufacturers to focus on technological innovation, product differentiation, and improved treatment efficiency to sustain their market position.

This report categorizes the Asia Pacific periodontal disease treatment market into product, disease, treatment, end user, and country.

“Gingivitis segment held largest share of Asia Pacific periodontal disease treatment market in 2025.”

The Asia Pacific periodontal disease treatment market is categorized based on the type of disease into four segments: gingivitis, acute periodontitis, aggressive periodontitis, and others. The largest market share is attributed to gingivitis treatment, which is driven by the high prevalence of gingivitis worldwide. Gingivitis is a mild form of periodontal disease that affects a significant portion of the population, mainly due to factors such as poor oral hygiene, lifestyle choices like smoking, and health conditions such as diabetes. This widespread occurrence leads to a high demand for preventive procedures, including dental scaling operations.

“Equipment segment accounted for majority of Asia Pacific periodontal disease treatment market in 2025.”

Based on product, the Asia Pacific periodontal disease treatment market is classified into equipment, consumables, and medication. The equipment segment accounted for the largest share of the Asia Pacific periodontal disease treatment market. The significant share of the equipment segment can be attributed to several interconnected factors. One primary reason is the growing demand for accurate and early diagnosis of dental diseases, driven by the increasing prevalence of oral health issues such as dental caries, periodontal diseases, and oral cancers. Advanced diagnostic equipment enables clinicians to identify these conditions at earlier stages, resulting in improved treatment outcomes and higher patient satisfaction.
Additionally, the rise in the establishment of hospitals, dental clinics, and specialized dental care centers, particularly in emerging economies, has greatly increased the adoption of modern dental equipment. New healthcare facilities are now being equipped with state-of-the-art diagnostic and treatment devices to enhance service quality and operational efficiency.

“Non-surgical treatment segment captured larger share of Asia Pacific periodontal disease treatment market in 2025.”

The Asia Pacific market for treating periodontal disease is segmented into non-surgical and surgical treatments, including flap surgery, soft tissue grafting, bone grafting, and guided tissue regeneration. The non-surgical treatment held the largest share because many patients prefer less invasive options that lead to quicker recovery and are more cost-effective. Common non-surgical methods for managing early-stage periodontal disease include deep cleaning (scaling and root planing), the use of antimicrobial agents, and laser therapy. These treatments are often the first line of defense, as they help control infections, remove plaque and tartar from below the gum line, and promote healing without the need for surgery.

“Hospitals accounted for majority share of Asia Pacific periodontal disease treatment market in 2025.”

Based on end user, the Asia Pacific periodontal disease treatment market is segmented into hospitals, private and DSO clinics, and academic and research institutes. The hospitals segment accounted for the largest share of the Asia Pacific periodontal disease treatment market. The large share and high growth rate of the hospitals segment can be attributed to a combination of structural, technological, and demand-driven factors. The increasing establishment of dental hospitals and multispecialty healthcare facilities has significantly expanded the patient base, as these institutions are often preferred for comprehensive and specialized dental care services. Dental hospitals are equipped to handle high patient volumes and complex procedures, which drives consistent demand for advanced dental technologies.

“China captured largest share of Asia Pacific periodontal disease treatment market in 2025.”

Based on country, the Asia Pacific periodontal disease treatment market is segmented into China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. China accounted for the largest share of the Asia Pacific periodontal disease treatment market due to several factors, including demographic, epidemiological, and healthcare system perspectives. The country's huge population base, increasing prevalence of periodontal diseases, and other oral health disorders have been the major drivers for surging demand for periodontal treatments. Rapid urbanization, changing dietary habits, smoking, and an aging population have led to increased rates of gum disease and tooth loss, including edentulism, in China. Over the past 10 years, China has made significant progress in healthcare infrastructure and dental care accessibility. The government has emphasized oral health awareness, while rising disposable incomes and a greater willingness to seek professional dental care have further stimulated the market. Additionally, the expansion of domestic and international dental equipment manufacturers, along with investments in advanced dental technologies and local manufacturing facilities, has improved product availability and affordability. Together, these factors have established China as the largest contributor to the periodontal disease treatment market in the Asia Pacific region.

Key Market Players:

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Some prominent players operating in the market include DENTSPLY SIRONA Inc. (US), Envista  (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Institut Straumann AG (Switzerland), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), Geistlich Pharma AG (Switzerland), RTI Surgical (US), and Keystone Dental Group (US).

Don’t miss out on business opportunities in Asia Pacific Periodontal Disease Treatment Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com